EDGAR Filing Documents for 0001493152-23-017639

Form 8-K - Current report:

SEC Accession No. 0001493152-23-017639

Filing Date

2023-05-16

Accepted

2023-05-16 08:01:38

Documents

Period of Report

2023-05-15

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm iXBRL	8-K	95850
2		ex10-1.htm	EX-10.1	443085
3		ex10-2.htm	EX-10.2	225101
4		ex10-3.htm	EX-10.3	102651
5		ex10-4.htm	EX-10.4	298405
6		ex10-5.htm	EX-10.5	449912
7		ex10-6.htm	EX-10.6	213033
8		ex99-1.htm	EX-99.1	16856
9		ex99-1_001.jpg	GRAPHIC	3404
	Complete submission text file	0001493152-23-017639.txt		2459998

Data Files

Seq	Description	Document	Type	Size
10	XBRL SCHEMA FILE	ocea-20230515.xsd	EX-101.SCH	4070
11	XBRL DEFINITION FILE	ocea-20230515_def.xml	EX-101.DEF	27188
12	XBRL LABEL FILE	ocea-20230515_lab.xml	EX-101.LAB	37603
13	XBRL PRESENTATION FILE	ocea-20230515_pre.xml	EX-101.PRE	25809
15	EXTRACTED XBRL INSTANCE DOCUMENT	form8-k_htm.xml	XML	5974

Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022

Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658

Ocean Biomedical, Inc. (Filer) CIK: 0001869974 (see all company filings)